Donate Now
Research Grants - 2005


Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2005


To view an abstract, select an author from the vertical list on the left side.

2005 Grant - D'Adamio

Role of Membrane Proteins in APP Processing and Signaling

Luciano D'Adamio, M.D., Ph.D.
Albert Einstein College of Medicine
Bronx, New York

2005 Investigator-Initiated Research Grant

The beta-amyloid protein fragment, a key suspect in Alzheimer's disease processes, is released from the much larger amyloid precursor protein (APP). It is not yet clear why this occurs or what role the process might have in the normal and diseased brain. However, structural and behavioral similarities between APP and another well-studied protein called Notch, suggests that beta-amyloid might be released when APP binds to some specific protein partners called ligands.

Luciano D'Adamio, M.D., Ph.D., and colleagues recently identified a protein called CD74 as a potential ligand for APP. Both CD74 and APP are found bound to the membrane that surrounds cells, particularly neurons, and the researchers found that CD74 can interfere with the release of beta-amyloid.

To verify if CD74 is a true APP ligand, the researchers will study the interaction between the two proteins in depth. They will determine if CD74 is essential for beta-amyloid production by measuring the protein fragment's release from neurons that have had CD74 removed. They will also determine what parts of APP and CD74 are involved in their interaction. The information may be useful for the design of small molecules that could interfere with beta-amyloid production and serve as therapeutics for Alzheimer's disease.